GL PHARMA EESTI OÜ
Date of report 10.01.2025
GL PHARMA EESTI OÜ
Former names
- Osaühing Lannacher Eesti
start | end |
---|---|
10.01.2007 | - |
keywords
- meedia ja trükk
- reklaamiagentuurid
GL PHARMA EESTI OÜ
Scores and ratings
Reputation score
Credit Score
Open the reports you want to print
Employees and salaries
GL PHARMA EESTI OÜ
Employee taxes and performance analysisQuarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
---|---|---|---|---|
2024 III | ...... | ...... | ...... | ...... |
2024 II | ...... | ...... | ...... | ...... |
2024 I | ...... | ...... | ...... | ...... |
2023 IV | ...... | ...... | ...... | ...... |
2023 III | ...... | ...... | ...... | ...... |
2023 II | ...... | ...... | ...... | ...... |
2023 I | ...... | ...... | ...... | ...... |
2022 IV | ...... | ...... | ...... | ...... |
2022 III | ...... | ...... | ...... | ...... |
2022 II | ...... | ...... | ...... | ...... |
2022 I | ...... | ...... | ...... | ...... |
2021 IV | ...... | ...... | ...... | ...... |
2021 III | ...... | ...... | ...... | ...... |
2021 II | ...... | ...... | ...... | ...... |
2021 I | ...... | ...... | ...... | ...... |
2020 IV | ...... | ...... | ...... | ...... |
2020 III | ...... | ...... | ...... | ...... |
2020 II | ...... | ...... | ...... | ...... |
2020 I | ...... | ...... | ...... | ...... |
2019 IV | ...... | ...... | ...... | ...... |
2019 III | ...... | ...... | ...... | ...... |
2019 II | ...... | ...... | ...... | ...... |
2019 I | ...... | ...... | ...... | ...... |
2018 IV | ...... | ...... | ...... | ...... |
2018 III | ...... | ...... | ...... | ...... |
2018 II | ...... | ...... | ...... | ...... |
2018 I | ...... | ...... | ...... | ...... |
2017 IV | ...... | ...... | ...... | ...... |
2017 III | ...... | ...... | ...... | ...... |
2017 II | ...... | ...... | ...... | ...... |
2017 I | ...... | ...... | ...... | ...... |
2016 IV | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
GL PHARMA EESTI OÜ
Decision-makersFormer decision-makers
......
Credit Score: Trustworthy
Reputation score: 970
Date of birth: ......
Active relations 2
0 followers
......
Credit Score: Neutral
Reputation score: 2090
Date of birth: ......
Active relations 2
0 followers
GL PHARMA EESTI OÜ
Former decision-makers......
Credit Score: Trustworthy
Reputation score: 850
Date of birth: ......
Active relations 1
4 followers
GL PHARMA EESTI OÜ
History of right of representationGL PHARMA EESTI OÜ
OwnersFormer owners
Finances and assets
GL PHARMA EESTI OÜ
GoodwillGL PHARMA EESTI OÜ
Taxes paid and estimated average salariesGL PHARMA EESTI OÜ
Quarterly indicatorsQuarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
---|---|---|---|---|---|---|---|
2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
GL PHARMA EESTI OÜ
Sales revenue by business areaGL PHARMA EESTI OÜ
Sales revenue by countryGL PHARMA EESTI OÜ
Financial indicators and prognosisGL PHARMA EESTI OÜ
Financial raiting: "GOOD" (2024 prognosis)GL PHARMA EESTI OÜ
Annual reportsYear | Period | Submitted | Report PDF |
---|---|---|---|
2023 | 01.01.2023–31.12.2023 | 01.07.2024 | ...... |
2022 | 01.01.2022–31.12.2022 | 08.05.2023 | ...... |
2021 | 01.01.2021–31.12.2021 | 02.06.2022 | ...... |
2020 | 01.01.2020–31.12.2020 | 06.05.2021 | ...... |
2019 | 01.01.2019–31.12.2019 | 19.06.2020 | ...... |
2018 | 01.01.2018–31.12.2018 | 20.06.2019 | ...... |
2017 | 01.01.2017–31.12.2017 | 25.06.2018 | ...... |
2016 | 01.01.2016–31.12.2016 | 29.06.2017 | ...... |
2015 | 01.01.2015–31.12.2015 | 27.06.2016 | ...... |
2014 | 01.01.2014–31.12.2014 | 16.06.2015 | ...... |
2013 | 01.01.2013–31.12.2013 | 29.05.2014 | ...... |
2012 | 01.01.2012–31.12.2012 | 17.06.2013 | ...... |
2011 | 01.01.2011–31.12.2011 | 29.06.2012 | ...... |
2010 | 01.01.2010–31.12.2010 | 15.06.2011 | ...... |
2009 | 01.01.2009–31.12.2009 | 29.06.2010 | ...... |
2008 | 01.01.2008–31.12.2008 | 01.07.2009 | ...... |
2007 | 01.01.2007–31.12.2007 | 22.08.2008 | ...... |
Liabilities and debts
GL PHARMA EESTI OÜ
Credit score history and prognosis... €
......
Business risk classes:
Trustworthy NeutralGL PHARMA EESTI OÜ
Reports and assets-liabilities overview 10.01.2025GL PHARMA EESTI OÜ
Claims historyTotal debt claims: ...... €
...... | ...... |
GL PHARMA EESTI OÜ
Income (turnover) and expenditure (taxes paid)Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
---|---|---|---|---|---|
2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
GL PHARMA EESTI OÜ
Bailiff's enforcement proceedings as of 10.01.2025Bailiff's enforcement proceedings MISSING
GL PHARMA EESTI OÜ
Regulations of the Payment Order Department as of 10.01.2025Regulations of the Payment Order Department MISSING
GL PHARMA EESTI OÜ
Court orders in the register as of 10.01.2025Court order MISSING
GL PHARMA EESTI OÜ
Decisions of the Consumer Disputes Committee as of 10.01.2025Consumer disputes MISSING
GL PHARMA EESTI OÜ
Court hearings as of 10.01.2025Court hearings MISSING
GL PHARMA EESTI OÜ
Rulings as of 10.01.2025Court settlemets MISSING
GL PHARMA EESTI OÜ
Notices and announcements as of 10.01.2025Announcements MISSING
Marketing
Business network
GL PHARMA EESTI OÜ
Business networkSign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
GL PHARMA EESTI OÜ
Networks - BeneficiariesSign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.